company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1494000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3432000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4926000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4926000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4434000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4432000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9358000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9358000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9358000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,973000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10331000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,467167.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q1,2013-01-01,2013-03-31,2014-05-28 16:22:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2525000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4538000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7063000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7063000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,918000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,919000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6144000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6144000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6144000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1123000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7267000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-14.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-14.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,507055.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 20:40:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-14.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3002000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6163000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9165000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9165000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2187000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2188000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6977000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6977000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6977000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2057000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9034000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-16.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-16.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,553790.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:01:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-16.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2594000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7654000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10248000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10248000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10239000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10239000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10239000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2214000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12453000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,500000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,522102.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.11
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2657000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9219000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11876000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11876000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1126000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1128000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10748000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10748000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10748000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3070000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13818000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-24.49
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-24.49
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,564186.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:08:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-24.49
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2513000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9125000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11638000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11638000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1467000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1471000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10167000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10167000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10167000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6084000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16251000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17900000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17900000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17888171.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 17:00:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2566000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10244000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12810000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12810000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12798000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12798000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12798000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12798000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21759061.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:04:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3127000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10891000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14018000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14018000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,64000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13954000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13954000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13954000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13954000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,22.45
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,22.45
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16054452.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.45
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3064000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11753000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14817000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14817000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14758000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14758000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14758000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14758000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23972599.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:34:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3533000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11545000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15078000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15078000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15106000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15106000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15106000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15106000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24000000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24000000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23996527.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:10:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2689000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9646000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12335000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12335000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,35000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24025481.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:04:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3061000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6829000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9890000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9890000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9859000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9859000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9859000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9859000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25100000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25152948.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2799000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6857000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9656000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9656000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,60000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,67000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9589000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9589000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9589000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9589000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30900000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30900000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30563088.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q1,2016-01-01,2016-03-31,2016-05-09 16:34:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2688000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6858000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9546000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9546000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,78000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9468000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9468000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9468000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9468000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31247069.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:26:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2770000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7469000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10239000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10239000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10178000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10178000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10178000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10178000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31645838.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 16:17:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2963000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8862000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11825000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11825000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,91000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11734000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11734000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11734000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11734000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31387579.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3059000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9628000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12687000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12687000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,85000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12602000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12602000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12602000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12602000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32645103.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:17:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2715000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9834000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12549000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12549000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,169000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,142000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12407000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12407000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12407000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12407000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42207376.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:15:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2950000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9689000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12639000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12639000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,187000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,158000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12481000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12481000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12481000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12481000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41600000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42207376.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q3,2017-07-01,2017-09-30,2017-10-25 16:17:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4590000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10190000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14780000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14780000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,197000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,192000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14588000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14588000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14588000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14588000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39859009.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4335000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10157000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14492000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14492000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,170000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-66000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14388000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14388000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14388000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14388000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42368864.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q1,2018-01-01,2018-03-31,2019-04-10 16:18:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,513000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2157000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2670000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.15
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.15
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,846953.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:11:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.15
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,395000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1410000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1805000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1805000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1797000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1797000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1797000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1797000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.12
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.12
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,846953.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:13:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.12
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-2841000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-4129000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-6970000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6970000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-171000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,514000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.02
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.02
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,846953.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.02
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1307000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3355000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4662000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4662000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,349000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,349000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4313000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.09
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.09
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,846953.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 08:13:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.09
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8978000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6029000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15007000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15007000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,259000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,293000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14714000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14714000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14714000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14714000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.52
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.52
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9669129.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:11:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.52
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2075000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7102000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9177000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9177000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,58000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,904000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,962000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8215000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8215000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8215000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8215000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10000000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10000000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10022856.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2160000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6026000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8186000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8186000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,480000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,495000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7691000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7691000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7691000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7691000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.91
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7700000.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.91
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7722269.0
Vital Therapies Inc,VTL,549300R5T12FW5MEQB20,0001280776,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.91
